WO2002012232A1 - Tartrate salt of thiazolidinedione derivative - Google Patents
Tartrate salt of thiazolidinedione derivative Download PDFInfo
- Publication number
- WO2002012232A1 WO2002012232A1 PCT/GB2001/003511 GB0103511W WO0212232A1 WO 2002012232 A1 WO2002012232 A1 WO 2002012232A1 GB 0103511 W GB0103511 W GB 0103511W WO 0212232 A1 WO0212232 A1 WO 0212232A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tartrate
- solvate
- accordance
- compound according
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Abstract
Description
Claims
Priority Applications (25)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UA2003020938A UA76720C2 (en) | 2000-08-04 | 2001-03-08 | Tartrate salt of thiazolidine derivative |
DZ013418A DZ3418A1 (en) | 2000-08-04 | 2001-08-03 | THIAZOLIDINEDIONE DERIVATIVE TARTRATE SALTS |
APAP/P/2003/002736A AP1785A (en) | 2000-08-04 | 2001-08-03 | Tartrate salt of thiazolidinedione derivative. |
US10/343,845 US20040014790A1 (en) | 2000-08-04 | 2001-08-03 | Tartrate salt of thiazolidinedione derivative |
PL36066201A PL360662A1 (en) | 2000-08-04 | 2001-08-03 | Tartrate salt of thiazolidinedione derivative |
EP01954159A EP1305311B1 (en) | 2000-08-04 | 2001-08-03 | Tartrate salt of thiazolidinedione derivative |
CA002417827A CA2417827A1 (en) | 2000-08-04 | 2001-08-03 | Tartrate salt of thiazolidinedione derivative |
HU0300778A HUP0300778A3 (en) | 2000-08-04 | 2001-08-03 | Tartrate sal of thiazolidinedione derivative |
SK146-2003A SK1462003A3 (en) | 2000-08-04 | 2001-08-03 | Tartrate salt of thiazolidinedione derivative |
NZ524030A NZ524030A (en) | 2000-08-04 | 2001-08-03 | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine2,4-dione, DL-tartrate salt or a solvate thereof |
AU2001276506A AU2001276506A1 (en) | 2000-08-04 | 2001-08-03 | Tartrate salt of thiazolidinedione derivative |
MXPA03001085A MXPA03001085A (en) | 2000-08-04 | 2001-08-03 | Tartrate salt of thiazolidinedione derivative. |
SI200130808T SI1305311T1 (en) | 2000-08-04 | 2001-08-03 | Tartrate salt of thiazolidinedione derivative |
DE60132461T DE60132461T2 (en) | 2000-08-04 | 2001-08-03 | TARTRATE SALT OF A THIAZOLIDE INDION DERIVATIVE |
EA200300230A EA005408B1 (en) | 2000-08-04 | 2001-08-03 | Tartrate salt of thiazolidinedione derivatives |
KR1020037001604A KR100755174B1 (en) | 2000-08-04 | 2001-08-03 | Tartrate Salt of Thiazolidinedione Derivative |
IL15427501A IL154275A0 (en) | 2000-08-04 | 2001-08-03 | Tartrate salts of thiazolidinedione derivative |
BR0112982-1A BR0112982A (en) | 2000-08-04 | 2001-08-03 | Thiazolidinedione derivative tartrate salt |
DK01954159T DK1305311T3 (en) | 2000-08-04 | 2001-08-03 | Tartrate salt of thiazolidinedione derivative |
JP2002518207A JP2004505970A (en) | 2000-08-04 | 2001-08-03 | Tartrate salt of thiazolidinedione derivative |
NO20030530A NO324596B1 (en) | 2000-08-04 | 2003-02-03 | Tartrate salts of thiazolidinedione derivative, process for the preparation thereof, pharmaceutical preparation and use of the tartrate salt |
IL154275A IL154275A (en) | 2000-08-04 | 2003-02-03 | 5 - [4 - [2 - (n - methyl - n - (2 - pyridyl) amino) ethoxy] benzyl] - thiazolidine - 2, 4 - dione, dl tartrates, their preparation and use thereof in the preparation of medicaments |
HR20030068A HRP20030068B1 (en) | 2000-08-04 | 2003-02-03 | Tartrate salt of thiazolidinedione derivative |
BG107604A BG107604A (en) | 2000-08-04 | 2003-02-28 | Tartarate salt of thiazolidinedione derivative |
HK03107709A HK1057358A1 (en) | 2000-08-04 | 2003-10-24 | Tartrate salt of thiazolidinedione derivative |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0019224.5A GB0019224D0 (en) | 2000-08-04 | 2000-08-04 | Novel pharmaceutical |
GB0019224.5 | 2000-08-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002012232A1 true WO2002012232A1 (en) | 2002-02-14 |
Family
ID=9897026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/003511 WO2002012232A1 (en) | 2000-08-04 | 2001-08-03 | Tartrate salt of thiazolidinedione derivative |
Country Status (37)
Country | Link |
---|---|
US (1) | US20040014790A1 (en) |
EP (1) | EP1305311B1 (en) |
JP (1) | JP2004505970A (en) |
KR (1) | KR100755174B1 (en) |
CN (1) | CN1455778A (en) |
AP (1) | AP1785A (en) |
AT (1) | ATE384059T1 (en) |
AU (1) | AU2001276506A1 (en) |
BG (1) | BG107604A (en) |
BR (1) | BR0112982A (en) |
CA (1) | CA2417827A1 (en) |
CY (1) | CY1107252T1 (en) |
CZ (1) | CZ2003313A3 (en) |
DE (1) | DE60132461T2 (en) |
DK (1) | DK1305311T3 (en) |
DZ (1) | DZ3418A1 (en) |
EA (1) | EA005408B1 (en) |
EC (1) | ECSP034467A (en) |
ES (1) | ES2296772T3 (en) |
GB (1) | GB0019224D0 (en) |
HK (1) | HK1057358A1 (en) |
HR (1) | HRP20030068B1 (en) |
HU (1) | HUP0300778A3 (en) |
IL (2) | IL154275A0 (en) |
MA (1) | MA25832A1 (en) |
MX (1) | MXPA03001085A (en) |
NO (1) | NO324596B1 (en) |
NZ (1) | NZ524030A (en) |
OA (1) | OA12354A (en) |
PL (1) | PL360662A1 (en) |
PT (1) | PT1305311E (en) |
SI (1) | SI1305311T1 (en) |
SK (1) | SK1462003A3 (en) |
UA (1) | UA76720C2 (en) |
WO (1) | WO2002012232A1 (en) |
YU (1) | YU14603A (en) |
ZA (1) | ZA200300961B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
WO2007009799A1 (en) * | 2005-07-22 | 2007-01-25 | Ratiopharm Gmbh | Amino acid salts of rosiglitazone |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7435741B2 (en) * | 2006-05-09 | 2008-10-14 | Teva Pharmaceutical Industries, Ltd. | 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
WO2017072770A1 (en) | 2015-10-27 | 2017-05-04 | Nanopass Technologies Ltd. | Microneedle device with mechanical guide |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994005659A1 (en) * | 1992-09-05 | 1994-03-17 | Smithkline Beecham Plc | Substituted thiazolidinedione derivatives |
-
2000
- 2000-08-04 GB GBGB0019224.5A patent/GB0019224D0/en not_active Ceased
-
2001
- 2001-03-08 UA UA2003020938A patent/UA76720C2/en unknown
- 2001-08-03 NZ NZ524030A patent/NZ524030A/en unknown
- 2001-08-03 CA CA002417827A patent/CA2417827A1/en not_active Abandoned
- 2001-08-03 US US10/343,845 patent/US20040014790A1/en not_active Abandoned
- 2001-08-03 EP EP01954159A patent/EP1305311B1/en not_active Expired - Lifetime
- 2001-08-03 ES ES01954159T patent/ES2296772T3/en not_active Expired - Lifetime
- 2001-08-03 YU YU14603A patent/YU14603A/en unknown
- 2001-08-03 DK DK01954159T patent/DK1305311T3/en active
- 2001-08-03 KR KR1020037001604A patent/KR100755174B1/en not_active IP Right Cessation
- 2001-08-03 AP APAP/P/2003/002736A patent/AP1785A/en active
- 2001-08-03 MX MXPA03001085A patent/MXPA03001085A/en active IP Right Grant
- 2001-08-03 PL PL36066201A patent/PL360662A1/en not_active Application Discontinuation
- 2001-08-03 IL IL15427501A patent/IL154275A0/en active IP Right Grant
- 2001-08-03 OA OA1200300028A patent/OA12354A/en unknown
- 2001-08-03 HU HU0300778A patent/HUP0300778A3/en unknown
- 2001-08-03 SI SI200130808T patent/SI1305311T1/en unknown
- 2001-08-03 EA EA200300230A patent/EA005408B1/en not_active IP Right Cessation
- 2001-08-03 AT AT01954159T patent/ATE384059T1/en not_active IP Right Cessation
- 2001-08-03 PT PT01954159T patent/PT1305311E/en unknown
- 2001-08-03 DZ DZ013418A patent/DZ3418A1/en active
- 2001-08-03 CN CN01815600A patent/CN1455778A/en active Pending
- 2001-08-03 SK SK146-2003A patent/SK1462003A3/en unknown
- 2001-08-03 BR BR0112982-1A patent/BR0112982A/en not_active IP Right Cessation
- 2001-08-03 JP JP2002518207A patent/JP2004505970A/en not_active Withdrawn
- 2001-08-03 CZ CZ2003313A patent/CZ2003313A3/en unknown
- 2001-08-03 WO PCT/GB2001/003511 patent/WO2002012232A1/en active IP Right Grant
- 2001-08-03 DE DE60132461T patent/DE60132461T2/en not_active Expired - Fee Related
- 2001-08-03 AU AU2001276506A patent/AU2001276506A1/en not_active Abandoned
-
2003
- 2003-02-03 HR HR20030068A patent/HRP20030068B1/en not_active IP Right Cessation
- 2003-02-03 IL IL154275A patent/IL154275A/en not_active IP Right Cessation
- 2003-02-03 NO NO20030530A patent/NO324596B1/en not_active IP Right Cessation
- 2003-02-03 MA MA27024A patent/MA25832A1/en unknown
- 2003-02-04 EC EC2003004467A patent/ECSP034467A/en unknown
- 2003-02-04 ZA ZA200300961A patent/ZA200300961B/en unknown
- 2003-02-28 BG BG107604A patent/BG107604A/en unknown
- 2003-10-24 HK HK03107709A patent/HK1057358A1/en not_active IP Right Cessation
-
2008
- 2008-03-19 CY CY20081100309T patent/CY1107252T1/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994005659A1 (en) * | 1992-09-05 | 1994-03-17 | Smithkline Beecham Plc | Substituted thiazolidinedione derivatives |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
WO2007009799A1 (en) * | 2005-07-22 | 2007-01-25 | Ratiopharm Gmbh | Amino acid salts of rosiglitazone |
EA012594B1 (en) * | 2005-07-22 | 2009-10-30 | Рациофарм Гмбх | Amino acid salts of rosiglitazone |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1305312B1 (en) | Tartrate salts of thiazolidinedione derivative | |
WO2002051839A1 (en) | 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt | |
EP1305311B1 (en) | Tartrate salt of thiazolidinedione derivative | |
NZ524548A (en) | The hydrochloride salt of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione | |
AU2001292028B2 (en) | Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione | |
WO2002020517A1 (en) | A thiazolidinedione derivative and its use as antidiabetic | |
AU2001276508A1 (en) | Tartrate salts of thiazolidinedione derivative | |
WO2003050113A1 (en) | Hydrogensulfate salt of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy!benzyl!thia zolidine-2,4-dione | |
EP1305310B1 (en) | Tartrate salts of thiazolidinedione derivative | |
AU2001292028A1 (en) | Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione | |
AU2005229694B2 (en) | Tartrate salt of thiazolidinedione derivative | |
US20040102485A1 (en) | Tartrate salt of thiazolidinedione derivative | |
WO2003050111A1 (en) | Toluenesulfonate salts of a thiazolidinedione derivative | |
AU2001292034A1 (en) | A thiazolidinedione derivative and its use as antidiabetic | |
EP1325000A1 (en) | A thiazolidinedione derivative and its use as antidiabetic | |
WO2003050112A1 (en) | Toluenesulfonate hydrates of a thiazolidinedione derivative | |
WO2003050114A1 (en) | Sulfate salt of a thiazolidinedione derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: P-146/03 Country of ref document: YU |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1200300114 Country of ref document: VN |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2003-313 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: P20030068A Country of ref document: HR Ref document number: PA/a/2003/001085 Country of ref document: MX Ref document number: 154275 Country of ref document: IL Ref document number: 2001276506 Country of ref document: AU Ref document number: 2417827 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003/00961 Country of ref document: ZA Ref document number: 1462003 Country of ref document: SK Ref document number: 200300961 Country of ref document: ZA Ref document number: 1020037001604 Country of ref document: KR Ref document number: 2002518207 Country of ref document: JP Ref document number: 03008182 Country of ref document: CO |
|
WWE | Wipo information: entry into national phase |
Ref document number: 524030 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202/MUMNP/2003 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001954159 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 10760401 Country of ref document: BG Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200300230 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018156002 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 1020037001604 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2001954159 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10343845 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: DZP2003000050 Country of ref document: DZ |
|
WWP | Wipo information: published in national office |
Ref document number: PV2003-313 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 524030 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 524030 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001954159 Country of ref document: EP |